ES2238285T3 - Uso de bacterias acidolacticas en la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios reducidos. - Google Patents

Uso de bacterias acidolacticas en la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios reducidos.

Info

Publication number
ES2238285T3
ES2238285T3 ES00935083T ES00935083T ES2238285T3 ES 2238285 T3 ES2238285 T3 ES 2238285T3 ES 00935083 T ES00935083 T ES 00935083T ES 00935083 T ES00935083 T ES 00935083T ES 2238285 T3 ES2238285 T3 ES 2238285T3
Authority
ES
Spain
Prior art keywords
lactobacillus casei
lactobacillus
individuals
fermented
milk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00935083T
Other languages
English (en)
Spanish (es)
Inventor
Pere Pujol Amat
Eric Postaire
Jose Antonio Mateos Guardia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gervais Danone SA
Original Assignee
Gervais Danone SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26155225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2238285(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ES009901036A external-priority patent/ES2155782B1/es
Priority claimed from ES009901037A external-priority patent/ES2155783B1/es
Application filed by Gervais Danone SA filed Critical Gervais Danone SA
Application granted granted Critical
Publication of ES2238285T3 publication Critical patent/ES2238285T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
ES00935083T 1999-05-07 2000-05-05 Uso de bacterias acidolacticas en la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios reducidos. Expired - Lifetime ES2238285T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ES009901036A ES2155782B1 (es) 1999-05-07 1999-05-07 Utilizacion de bacterias acidolacticas pra preparar leches fermentadas para el tratamiento de niveles de actividad inmunitaria transitoriamente reducidos.
ES9901036 1999-05-07
ES009901037A ES2155783B1 (es) 1999-05-07 1999-05-07 Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
ES9901037 1999-05-07

Publications (1)

Publication Number Publication Date
ES2238285T3 true ES2238285T3 (es) 2005-09-01

Family

ID=26155225

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00935083T Expired - Lifetime ES2238285T3 (es) 1999-05-07 2000-05-05 Uso de bacterias acidolacticas en la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios reducidos.

Country Status (8)

Country Link
EP (1) EP1178730B1 (de)
AT (1) ATE291353T1 (de)
AU (1) AU5069500A (de)
DE (1) DE60018919T2 (de)
ES (1) ES2238285T3 (de)
MX (1) MXPA01011336A (de)
PT (1) PT1178730E (de)
WO (1) WO2000067583A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
CN108882740A (zh) * 2015-12-29 2018-11-23 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
CN109924506B (zh) * 2019-03-04 2021-06-04 山东环亿生物科技有限公司 一种具有减肥功能的益生菌组合物及其制备方法和应用
CN111944727B (zh) * 2020-08-24 2021-12-03 汤臣倍健股份有限公司 一种短双歧杆菌207-1及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2922013B2 (ja) * 1991-04-17 1999-07-19 雪印ローリー株式会社 耐酸性及び酸素耐性を有する新規ビフィズス菌
EP0649603B1 (de) * 1993-05-11 2000-10-25 Otsuka Pharmaceutical Co., Ltd. Antioxidans-nahrungsmittel, antioxidans-herstellung und methode zur verringerung der oxidation
EP0951531B1 (de) * 1996-11-29 2007-02-28 Bio K + International Inc. Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung
GB2338245B (en) * 1997-08-21 2001-11-21 New Zealand Dairy Board Immunity enhancing lactic acid bacteria

Also Published As

Publication number Publication date
AU5069500A (en) 2000-11-21
ATE291353T1 (de) 2005-04-15
EP1178730B1 (de) 2005-03-23
WO2000067583A3 (en) 2001-03-01
PT1178730E (pt) 2005-06-30
EP1178730A2 (de) 2002-02-13
DE60018919T2 (de) 2006-05-18
DE60018919D1 (de) 2005-04-28
MXPA01011336A (es) 2002-11-04
WO2000067583A2 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
Kadooka et al. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial
AU779414B2 (en) Lactobacillus strains preventing diarrhoea pathogenic bacteria
Montes et al. Effect of milks inoculated with Lactobacillus acidophilus or a yogurt starter culture in lactose-maldigesting children
Tiollier et al. Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training
ES2437940T3 (es) Composición probiótica para uso en el tratamiento de la inflamación del intestino
JP5785275B2 (ja) 単離された微生物菌株、ラクトバチルスプランタルム（ｌａｃｔｏｂａｃｉｌｌｕｓｐｌａｎｔａｒｕｍ）ｍｃｃ１ｄｓｍ２３８８１およびラクトバチルスガセリ（ｌａｃｔｏｂａｃｉｌｌｕｓｇａｓｓｅｒｉ）ｍｃｃ２ｄｓｍ２３８８２ならびにそれらの使用
JP5816273B2 (ja) 経上皮抵抗の改善に用いるためのプロバイオティクス株
ES2399775T3 (es) Composiciones farmacéuticas que comprenden L. acidophilus y bifidobacterium lactis para el uso en el tratamiento de un trastorno intestinal funcional
EP4358983A1 (de) Verfahren zur förderung des wohlbefindens und zur ermöglichung der selbstkontrolle vor, während und/oder nach einer restriktiven diät
ES2238285T3 (es) Uso de bacterias acidolacticas en la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios reducidos.
JP7225364B1 (ja) 乳酸菌
US9272007B2 (en) Strain of L. bulgaricus capable of inhibiting the adhesion of H. pylori strains to epithelial cells
Higashikawa et al. Lactobacillus plantarum SN13T cells improve hepatic dysfunction and fecal microbiota: A randomized pilot study
TAkII et al. Effects of intake of pickles containing Lactobacillus brevis on immune activity and bowel symptoms in female students
US12551516B2 (en) Composition for amelioration of anxiety and/or stress
Pawan et al. Systemic immunomodulation and hypocholesteraemia by dietary probiotics: a clinical study
Crane Pro and anti: the biotics of allergic disease
RU2815833C2 (ru) Композиция для облегчения тревожности и/или стресса
Naturopath Probiotics Aid Weight Loss and Body Fat Reduction
He The intestinal microbiota of the elderly
CN110402289A (zh) 利用胃内菌群的占有率测定的功能性消化道障碍的检测方法及胃内菌群改善剂
JP2022023806A (ja) 制御性ｔ細胞調節剤およびその用途
BG63963B1 (bg) Закваска за пробиотичен хранителен продукт и приложението му като имуномодулиращо средство
US20200155622A1 (en) Compositions and methods for decreasing a population of bilophila wadsworthia or inhibiting the growth thereof
HK40009684A (en) Method of detecting functional gastrointestinal disorder by measuring stomach flora occupancy, and stomach flora improving agent